Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-16-005296
Filing Date
2016-02-26
Accepted
2016-02-25 19:59:04
Documents
44
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K sibannac_10k-083115.htm 10-K 488577
2 CERTIFICATION sibannac_10k-ex3101.htm EX-31.1 6723
3 CETIFICATION sibannac_10k-ex3102.htm EX-31.2 6998
4 CERTIFICATION sibannac_10k-ex3201.htm EX-32.1 3766
5 CERTIFICATION sibannac_10k-ex3202.htm EX-32.2 3952
6 GRAPHIC image_001.jpg GRAPHIC 23049
7 GRAPHIC image_002.jpg GRAPHIC 33023
  Complete submission text file 0001019687-16-005296.txt   1589700

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE none-20150831.xml EX-101.INS 114130
9 XBRL SCHEMA FILE none-20150831.xsd EX-101.SCH 16083
10 XBRL CALCULATION FILE none-20150831_cal.xml EX-101.CAL 29158
11 XBRL DEFINITION FILE none-20150831_def.xml EX-101.DEF 35200
12 XBRL LABEL FILE none-20150831_lab.xml EX-101.LAB 125555
13 XBRL PRESENTATION FILE none-20150831_pre.xml EX-101.PRE 96329
Mailing Address 1313 E. OSBORN PHOENIX AZ 85014
Business Address 1313 E. OSBORN PHOENIX AZ 85014 480-420-3171
Sibannac, Inc. (Filer) CIK: 0001313938 (see all company filings)

EIN.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-55578 | Film No.: 161457582
SIC: 2834 Pharmaceutical Preparations